Diabetic Neuropathy & Peripheral Nerve Repair
Diabetic Neuropathy & Peripheral Nerve Repair framework focused on consistent execution, practical monitoring, and safer progression.
Targeted repair protocol for peripheral and small fiber neuropathy caused by diabetes, chemotherapy, or chronic inflammation. Restores nerve fiber density and reduces neuropathic pain.
Who it's for
Use this as an educational framework with clinical oversight. Keep timing consistent, track response daily, and change one variable at a time after trend review. Pair protocol use with sleep, nutrition, and recovery fundamentals.
Free Peptide Guide
Diabetic Neuropathy & Peripheral Nerve Repair Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.
Protocol at a Glance
Cycle Duration
24 weeks minimum; ARA-290 14–28-day intense courses then maintenance. Others continuous.
Target Audience
Diabetic peripheral neuropathy, chemotherapy-induced neuropathy, small fiber neuropathy, chronic neuropathic pain
| Compound | Dose | Frequency |
|---|---|---|
| ARA-290 Most direct clinical evidence for small fiber neuropathy; tissue-protective EPO receptor | 4 mcg/kg | Daily for 28 days, then 3x/week maintenance |
| BPC-157 Nerve regeneration, VEGFR2 upregulation, neurotrophic factor induction | 250 mcg | Twice daily |
| NAD+ Restores axonal mitochondrial function; PGC-1α pathway activation in neural tissue | 500 mg | Daily |
| GHK-Cu VEGF and nerve growth factor induction; microvascular repair to nerves | 2 mg subcutaneous | 3x per week |
| SS-31 (Elamipretide) Axonal mitochondrial protection; reduces ROS-driven neuropathic pain sensitization | 0.1 mg/kg | Daily |
Free Peptide Guide
Diabetic Neuropathy & Peripheral Nerve Repair Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.
Daily Schedule
Morning
Baseline review and first execution window
Log sleep, energy, and tolerance; complete planned ARA-290 timing if scheduled.
Midday
Adherence and symptom check
Review hydration, workload, and side effects before any changes.
Evening
Recovery closeout and next-day setup
Record outcomes, maintain schedule consistency, and prepare next-day protocol.
Safety
- Escalating side effects or new concerning symptoms require prompt clinical review.
- Avoid abrupt multi-compound changes during unstable periods.
- Maintain regular follow-up with a licensed clinician throughout the cycle.
Not appropriate for unsupervised use or as a replacement for diagnosis and medical care. Use only within a clinician-guided plan.
Who should avoid
- Anyone using this protocol without qualified medical supervision
- People with unstable medical or psychiatric conditions without specialist guidance
- Pregnant or breastfeeding individuals unless explicitly cleared by a physician
Common Mistakes
Changing multiple variables at once
Why it matters: This makes it hard to identify what improved outcomes versus what increased side effects.
How to fix: Keep one-variable changes per review cycle and log response for several days.
Ignoring adherence and recovery fundamentals
Why it matters: Protocol effectiveness drops when sleep, nutrition, and routine consistency are unstable.
How to fix: Protect daily anchors first, then optimize protocol details gradually.
FAQ
How long should Diabetic Neuropathy & Peripheral Nerve Repair run before reassessment?
A common window is 24 weeks minimum; ARA-290 14–28-day intense courses then maintenance. Others continuous., with periodic review of tolerance and objective trends.
Can I increase complexity quickly for faster results?
Usually no. Safer optimization comes from staged changes and clear tracking.
What should I track each day?
Track schedule adherence, symptoms, sleep quality, and any adverse effects in one log.
Key Takeaways
- Consistency with ARA-290 + BPC-157 execution matters more than frequent protocol changes.
- Single-variable adjustments improve safety and decision quality.
- Objective daily tracking supports better long-term outcomes.
Why This Stack Works
ARA-290 has phase 2 clinical trial evidence specifically for small fiber neuropathy: increasing corneal nerve fiber density and reducing NRS pain scores by activating the tissue-protective EPO receptor on neural tissue. BPC-157 promotes peripheral nerve regeneration through VEGF, NO, and neurotrophic factor upregulation. NAD+ is critical for PGC-1α-mediated axonal mitochondrial function, severely impaired in diabetic neuropathy. GHK-Cu increases VEGF expression to restore microvascular supply to nerves. SS-31 addresses the mitochondrial dysfunction in axons that is central to neuropathic pain.
Clinical Research
No clinical references were provided for this stack yet.
More Recovery & Repair Stacks
ALS & Motor Neuron Disease Supportive Care
A neuroprotective peptide protocol for ALS and motor neuron disease, targeting mitochondrial function, neuroinflammation, and remaining motor neuron survival without interfering with standard-of-care riluzole therapy.
Acute Injury & Emergency Recovery Protocol
Rapid-response peptide protocol for acute injuries, post-surgical recovery, or critical illness support. Designed to initiate within 24–48 hours of injury or procedure.
Advanced Gut Restoration Protocol
The most comprehensive gut healing protocol, targeting intestinal permeability, mucosal growth, epithelial repair, and microbiome defense simultaneously. Suitable for celiac disease, post-antibiotic dysbiosis, IBD, short bowel syndrome, and chronic leaky gut.
Medical disclaimer: This protocol is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any peptide protocol.
Free Peptide Guide
Diabetic Neuropathy & Peripheral Nerve Repair Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.